Yan X - Search Results

1

Nanotechnology-Based Weapons to Combat Human Papillomavirus Infection Associated Diseases.

Pan L, Li B, Chen J, Zhang H, Wang X, Shou J, Yang D, Yan X. Pan L, et al. Among authors: yan x. Front Chem. 2021 Nov 17;9:798727. doi: 10.3389/fchem.2021.798727. eCollection 2021. Front Chem. 2021. PMID: 34869242 Free PMC article. Review.

2

Erastin Reverses ABCB1-Mediated Docetaxel Resistance in Ovarian Cancer.

Zhou HH, Chen X, Cai LY, Nan XW, Chen JH, Chen XX, Yang Y, Xing ZH, Wei MN, Li Y, Wang ST, Liu K, Shi Z, Yan XJ. Zhou HH, et al. Among authors: yan xj. Front Oncol. 2019 Dec 19;9:1398. doi: 10.3389/fonc.2019.01398. eCollection 2019. Front Oncol. 2019. PMID: 31921655 Free PMC article.

3

Comparison of laparoscopic and open radical hysterectomy in cervical cancer patients with tumor size ≤2 cm.

Chen X, Zhao N, Ye P, Chen J, Nan X, Zhao H, Zhou K, Zhang Y, Xue J, Zhou H, Shang H, Zhu H, Leanne VM, Yan X. Chen X, et al. Among authors: yan x. Int J Gynecol Cancer. 2020 May;30(5):564-571. doi: 10.1136/ijgc-2019-000994. Epub 2020 Apr 9. Int J Gynecol Cancer. 2020. PMID: 32276941

4

Identification and validation of a six-gene signature associated with glycolysis to predict the prognosis of patients with cervical cancer.

Cai L, Hu C, Yu S, Liu L, Yu X, Chen J, Liu X, Lin F, Zhang C, Li W, Yan X. Cai L, et al. Among authors: yan x. BMC Cancer. 2020 Nov 23;20(1):1133. doi: 10.1186/s12885-020-07598-3. BMC Cancer. 2020. PMID: 33228592 Free PMC article.

5

Construction and Validation of a Novel Glycometabolism-Related Gene Signature Predicting Survival in Patients With Ovarian Cancer.

Liu L, Cai L, Liu C, Yu S, Li B, Pan L, Zhao J, Zhao Y, Li W, Yan X. Liu L, et al. Among authors: yan x. Front Genet. 2020 Nov 12;11:585259. doi: 10.3389/fgene.2020.585259. eCollection 2020. Front Genet. 2020. PMID: 33281878 Free PMC article.

6

Clinical features and prognostic factors of cervical villoglandular adenocarcinoma.

Chen JH, Duan H, Yu XB, Zhao HW, Chen X, Li P, Li ZQ, Li BX, Pan LY, Yan X, Chen C. Chen JH, et al. Among authors: yan x. Int J Gynecol Cancer. 2021 Apr;31(4):512-517. doi: 10.1136/ijgc-2020-002044. Epub 2021 Feb 19. Int J Gynecol Cancer. 2021. PMID: 33608452

7

Recent Developments on Using Nanomaterials to Combat Candida albicans.

Li B, Pan L, Zhang H, Xie L, Wang X, Shou J, Qi Y, Yan X. Li B, et al. Among authors: yan x. Front Chem. 2021 Dec 23;9:813973. doi: 10.3389/fchem.2021.813973. eCollection 2021. Front Chem. 2021. PMID: 35004630 Free PMC article. Review.

8

Celastrol Inhibits the Growth of Ovarian Cancer Cells in vitro and in vivo.

Xu LN, Zhao N, Chen JY, Ye PP, Nan XW, Zhou HH, Jiang QW, Yang Y, Huang JR, Yuan ML, Xing ZH, Wei MN, Li Y, Shi Z, Yan XJ. Xu LN, et al. Front Oncol. 2019 Jan 28;9:2. doi: 10.3389/fonc.2019.00002. eCollection 2019. Front Oncol. 2019. PMID: 30746340 Free PMC article.

9

Survivin Promotes Piperlongumine Resistance in Ovarian Cancer.

Nan XW, Gong LH, Chen X, Zhou HH, Ye PP, Yang Y, Xing ZH, Wei MN, Li Y, Wang ST, Liu K, Shi Z, Yan XJ. Nan XW, et al. Among authors: yan xj. Front Oncol. 2019 Nov 29;9:1345. doi: 10.3389/fonc.2019.01345. eCollection 2019. Front Oncol. 2019. PMID: 31850227 Free PMC article.

10

High CA-125 and CA19-9 levels in spontaneous ruptured ovarian endometriomas.

Dai X, Jin C, Hu Y, Zhang Q, Yan X, Zhu F, Lin F. Dai X, et al. Among authors: yan x. Clin Chim Acta. 2015 Oct 23;450:362-5. doi: 10.1016/j.cca.2015.09.019. Epub 2015 Sep 25. Clin Chim Acta. 2015. PMID: 26403090

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

16,347 results

Search Page